Výsledky vyhledávání - "Bartlett, JB"

Akademický článek

Evaluation of high dose N- Acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: A randomised placebo-controlled pilot study.

Autor: Jayaram L; Western Health, Gordon Street, Footscray, VIC, 3011, Australia; University of Melbourne, Parkville, VIC, 3010, Australia. Electronic address: Lata.jayaram@wh.org.au., King PT; Monash Medical Centre, Clayton Road, Clayton, VIC, 3068, Australia; Monash University, Wellington Road, Clayton, VIC, 3068, Australia., Hunt J; Western Health, Gordon Street, Footscray, VIC, 3011, Australia., Lim M; Western Health, Gordon Street, Footscray, VIC, 3011, Australia., Park C; Western Health, Gordon Street, Footscray, VIC, 3011, Australia., Hu E; Western Health, Gordon Street, Footscray, VIC, 3011, Australia., Dousha L; Monash Medical Centre, Clayton Road, Clayton, VIC, 3068, Australia; Monash University, Wellington Road, Clayton, VIC, 3068, Australia., Ha P; Western Health, Gordon Street, Footscray, VIC, 3011, Australia., Bartlett JB; Western Health, Gordon Street, Footscray, VIC, 3011, Australia; University of Melbourne, Parkville, VIC, 3010, Australia., Southcott AM; Western Health, Gordon Street, Footscray, VIC, 3011, Australia; University of Melbourne, Parkville, VIC, 3010, Australia., Muruganandan S; University of Melbourne, Parkville, VIC, 3010, Australia; Northern Health, Epping, VIC, 3076 Australia., Vogrin S; University of Melbourne, Parkville, VIC, 3010, Australia., Rees MA; University of Melbourne, Parkville, VIC, 3010, Australia; Royal Melbourne Hospital, Gratten St, VIC, 3050, Australia., Dean OM; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, 3220 Australia; Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, VIC , 3010, Australia., Wong CA; Middlemore Hospital, Te Whatu Ora, Otahuhu, Auckland, 1025, New Zealand; University of Auckland, Park Road, Auckland, 1010, New Zealand.

Publikováno v: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2024 Mar; Vol. 84, pp. 102283. Date of Electronic Publication: 2023 Dec 22.

Zobrazit plný text záznamu

Akademický článek

Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX.

Autor: Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia., Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France., Mateos MV; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain., Goldschmidt H; University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases, Heidelberg, Germany., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Levin MD; Albert Schweitzer Hospital, Dordrecht, The Netherlands., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Reece D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Ahmadi T; Genmab US, Inc, Plainsboro, NJ., Pei H; Janssen Research & Development, LLC, Titusville, NJ., Mayo WG; Janssen Research & Development, LLC, Raritan, NJ., Gai X; Janssen Research & Development, LLC, Beijing, China., Carey J; Janssen Research & Development, LLC, Spring House, PA., Bartlett JB; Janssen Research & Development, LLC, Raritan, NJ., Carson R; Janssen Research & Development, LLC, Spring House, PA., Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.

Publikováno v: Blood advances [Blood Adv] 2024 Jan 23; Vol. 8 (2), pp. 388-398.

Zobrazit plný text záznamu

Akademický článek

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.

Autor: Sborov DW; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA., Baljevic M; Division of Oncology & Hematology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Reeves B; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Laubach J; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Efebera YA; OhioHealth, Columbus, Ohio, USA., Rodriguez C; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Costa LJ; University of Alabama at Birmingham, Birmingham, Alabama, USA., Chari A; Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, USA., Silbermann R; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Holstein SA; Divison of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Shah N; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Pei H; Janssen Research & Development, LLC, Titusville, New Jersey, USA., Patel S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Bartlett JB; Janssen Research & Development, LLC, Raritan, New Jersey, USA., Vermeulen J; Janssen Research & Development, LLC, Leiden, The Netherlands., Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Voorhees PM; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Richardson PG; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Nov; Vol. 199 (3), pp. 355-365. Date of Electronic Publication: 2022 Sep 16.

Zobrazit plný text záznamu

Report

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.

Autor: Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA. anooka@emory.edu., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Rodriguez C; Wake Forest University School of Medicine, Winston-Salem, NC, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA., Efebera Y; OhioHealth, Columbus, OH, USA., Reeves B; University of North Carolina-Chapel Hill, Chapel Hill, NC, USA., Wildes T; Cancer & Aging Research Group, St. Louis, MO, USA., Holstein SA; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Badros A; Greenbaum Cancer Center, University of Maryland, Baltimore, MD, USA., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Chari A; Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA., Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Patel S; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Bartlett JB; Janssen Research & Development, LLC, Raritan, NJ, USA., Vermeulen J; Janssen Research & Development, LLC, Leiden, the Netherlands., Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA., Voorhees P; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

Publikováno v: Blood cancer journal [Blood Cancer J] 2022 Apr 13; Vol. 12 (4), pp. 63. Date of Electronic Publication: 2022 Apr 13.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání